<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Legal Insider Trading Data | Free and Professional Subscription Services | Insider Insights</title>
<link href="http://www.insiderinsights.com/news/company/aktx" ></link>
<id>urn:uuid:542df8cc-0f78-b065-dd79-750ac56bc60a</id>
<updated>2026-11-13T17:17:35-05:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>AKTX: PRUDO CHLEBOSZ RAYMOND (DIR) Acquired (JB) 9,072 Shares of AKARI THERAPEUTICS PLC for $7.90 on 8/18</title>
<link href="http://www.insiderinsights.com/company/aktx/akari-therapeutics-plc/id-6481867" ></link>
<id>urn:uuid:f5533fa3-0f7c-812d-624d-3883d72cda2b</id>
<updated>2026-10-16T17:20:18-04:00</updated>
<summary type="html" ><![CDATA[AKARI THERAPEUTICS PLC (AKTX). Recent Price: $7.37. Mkt Cap:16.8mm. 10D Vol: 53,840]]></summary>
</entry>
<entry>
<title>AKTX: PRUDO CHLEBOSZ RAYMOND (DIR) Acquired (JB) 3,240 Shares of AKARI THERAPEUTICS PLC for $7.90 on 10/5</title>
<link href="http://www.insiderinsights.com/company/aktx/akari-therapeutics-plc/id-6481868" ></link>
<id>urn:uuid:f8006669-7a88-7c1b-1de1-a753acb8bf65</id>
<updated>2026-10-16T17:20:18-04:00</updated>
<summary type="html" ><![CDATA[AKARI THERAPEUTICS PLC (AKTX). Recent Price: $7.37. Mkt Cap:16.8mm. 10D Vol: 53,840]]></summary>
</entry>
<entry>
<title>AKTX: HUH HOYOUNG (DIR,BO) Acquired (JB) 17,249 Shares of AKARI THERAPEUTICS PLC for $7.90 on 8/18</title>
<link href="http://www.insiderinsights.com/company/aktx/akari-therapeutics-plc/id-6481869" ></link>
<id>urn:uuid:6936e840-0310-9202-c45d-0b58bc2ff357</id>
<updated>2026-10-16T17:20:16-04:00</updated>
<summary type="html" ><![CDATA[AKARI THERAPEUTICS PLC (AKTX). Recent Price: $7.37. Mkt Cap:16.8mm. 10D Vol: 53,840]]></summary>
</entry>
<entry>
<title>AKTX: HUH HOYOUNG (DIR,BO) Acquired (JB) 6,160 Shares of AKARI THERAPEUTICS PLC for $7.90 on 10/5</title>
<link href="http://www.insiderinsights.com/company/aktx/akari-therapeutics-plc/id-6481870" ></link>
<id>urn:uuid:ec0866cd-7ce7-cc49-e23e-6a150b142163</id>
<updated>2026-10-16T17:20:16-04:00</updated>
<summary type="html" ><![CDATA[AKARI THERAPEUTICS PLC (AKTX). Recent Price: $7.37. Mkt Cap:16.8mm. 10D Vol: 53,840]]></summary>
</entry>
<entry>
<title>AKTX: PATEL SANDIP I (DIR) Acquired (JB) 12,100 Shares of AKARI THERAPEUTICS PLC for $7.90 on 8/18</title>
<link href="http://www.insiderinsights.com/company/aktx/akari-therapeutics-plc/id-6481871" ></link>
<id>urn:uuid:aed01c15-c0f4-b12e-2010-7e4851115e42</id>
<updated>2026-10-16T17:20:13-04:00</updated>
<summary type="html" ><![CDATA[AKARI THERAPEUTICS PLC (AKTX). Recent Price: $7.37. Mkt Cap:16.8mm. 10D Vol: 53,840]]></summary>
</entry>
<entry>
<title>AKTX: PATEL SANDIP I (DIR) Acquired (JB) 4,313 Shares of AKARI THERAPEUTICS PLC for $7.90 on 10/5</title>
<link href="http://www.insiderinsights.com/company/aktx/akari-therapeutics-plc/id-6481872" ></link>
<id>urn:uuid:a8effbee-176c-0f2c-c8cb-4dd2f83e6cfb</id>
<updated>2026-10-16T17:20:13-04:00</updated>
<summary type="html" ><![CDATA[AKARI THERAPEUTICS PLC (AKTX). Recent Price: $7.37. Mkt Cap:16.8mm. 10D Vol: 53,840]]></summary>
</entry>
<entry>
<title>AKTX: PATEL SANDIP I (DIR) Exercised 10,052 Options (OB) of AKARI THERAPEUTICS PLC for $0.00 on 10/14, and Kept Them All</title>
<link href="http://www.insiderinsights.com/company/aktx/akari-therapeutics-plc/id-6481873" ></link>
<id>urn:uuid:c56b876b-094d-9ede-b99e-c1a2a76d3ec8</id>
<updated>2026-10-16T17:20:13-04:00</updated>
<summary type="html" ><![CDATA[AKARI THERAPEUTICS PLC (AKTX). Recent Price: $7.37. Mkt Cap:16.8mm. 10D Vol: 53,840]]></summary>
</entry>
<entry>
<title>AKTX: BAZEMORE ROBERT B (DIR) Acquired (JB) 13,100 Shares of AKARI THERAPEUTICS PLC for $7.90 on 8/18</title>
<link href="http://www.insiderinsights.com/company/aktx/akari-therapeutics-plc/id-6481874" ></link>
<id>urn:uuid:16a3b1ec-2fa1-29c7-129d-7ba140029b47</id>
<updated>2026-10-16T17:20:11-04:00</updated>
<summary type="html" ><![CDATA[AKARI THERAPEUTICS PLC (AKTX). Recent Price: $7.37. Mkt Cap:16.8mm. 10D Vol: 53,840]]></summary>
</entry>
<entry>
<title>AKTX: BAZEMORE ROBERT B (DIR) Acquired (JB) 4,677 Shares of AKARI THERAPEUTICS PLC for $7.90 on 10/5</title>
<link href="http://www.insiderinsights.com/company/aktx/akari-therapeutics-plc/id-6481875" ></link>
<id>urn:uuid:04f4bf79-8281-aabf-f707-c33c034315c4</id>
<updated>2026-10-16T17:20:11-04:00</updated>
<summary type="html" ><![CDATA[AKARI THERAPEUTICS PLC (AKTX). Recent Price: $7.37. Mkt Cap:16.8mm. 10D Vol: 53,840]]></summary>
</entry>
<entry>
<title>AKTX: BAZEMORE ROBERT B (DIR) Exercised 3,866 Options (OB) of AKARI THERAPEUTICS PLC for $0.00 on 10/14, and Kept Them All</title>
<link href="http://www.insiderinsights.com/company/aktx/akari-therapeutics-plc/id-6481876" ></link>
<id>urn:uuid:d334f445-1e7b-105e-88da-1afb04dee98e</id>
<updated>2026-10-16T17:20:11-04:00</updated>
<summary type="html" ><![CDATA[AKARI THERAPEUTICS PLC (AKTX). Recent Price: $7.37. Mkt Cap:16.8mm. 10D Vol: 53,840]]></summary>
</entry>
</feed>